Clinical And Molecular Investigation in Feline Infectious Peritonitis Cat Treated with Gs-441524 Contained Drug

An immune-mediated disease caused by a highly virulent Feline coronavirus (FCoV), Feline infectious peritonitis, is one of the most challenging diseases in cats due to its difficulty in either diagnosis or treatment. However, the recent investigation has offered some hope with the discovery of adenosine nucleoside analog GS-441524, which has shown promising results in terms of survival rates and clinical recoveries. This study demonstrated the effectiveness of GS-441524 for FIP treatment. A-two-year-old male mix breed was admitted to Satwakita Animal Clinic, Yogyakarta and examined by responsible veterinarian. Abdominal effusion was aseptically collected for further examination in Veterinary Medicine Clinical Pathology Laboratory, Universitas Gadjah Mada. The analysis utilized RT-qPCR targeting 5’UTR confirmed FCoV infection in the cat. The cat was treated by daily administration of the nucleoside analog GS-441524 by subcutaneously injection route for 40 days. The result of this treatment proves that GS-441524 effectively cured FIP and eliminated FCoV infection in the cat. In this case report, we showed that GS-441524 was effective in this cat. Both clinical signs and FCoV RNA were significantly reduced. The results highlight the promising potential of GS-441524 for treating FIP that naturally occurs in cats